source
- Sanofi eyes late-stage and commercial acquisitions to counter upcoming Dupixent revenue dropSanofi said on its third‑quarter earnings call that it is looking to acquire late‑stage and commercial medicines to sustain growth after Dupixent loses exclusivity. CEO Belén Garijo highlighted th…
- Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMOThe latest episode of STAT’s biotech podcast "The Readout LOUD" focused on the mRNA cancer vaccine being co‑developed by Merck and Moderna, using data shown at the European Society for Medical Onco…